Int'l AIDS forum kicks off in Rwanda's capital
The event, themed "Breakthroughs amid Crisis: the Future of HIV Innovation," has convened about 4,000 participants, including global leaders, researchers, scientists, and civil society members.
Speaking at the conference, Rwandan Minister of Health Sabin Nsanzimana said that Rwanda's experience in the HIV response over the past few decades demonstrates what is possible when countries prioritize people-centered approaches and invest in strategic partnerships.
"We have better tools for prevention and treatment. We have better ways to engage our communities to fight stigma and discrimination, and better integration within our systems. This means we can not only achieve HIV control, but we also need to strengthen our health systems," he added.
IAS President Beatriz Grinsztein underlined new World Health Organization (WHO) guidelines, groundbreaking licensing agreements, and promising research as signs that long-acting HIV prevention and treatment options are becoming more feasible for widespread use.
"Our next challenge is clear: leaders must commit the funding and resources needed to integrate these scientific advances into health systems quickly and equitably so that people everywhere can benefit from these life-changing options," Grinsztejn emphasized.
At the event, the WHO issued a statement announcing new guidelines that recommend using injectable lenacapavir twice a year as an additional pre-exposure prophylaxis option for HIV prevention -- a landmark policy action that could help reshape the global HIV response.
"While an HIV vaccine remains elusive, lenacapavir is the next best thing: a long-acting antiretroviral shown in trials to prevent almost all HIV infections among those at risk," WHO Director-General Tedros Adhanom Ghebreyesus is quoted as saying in the statement.
The IAS Conference on HIV Science is recognized as the world's most influential meeting on HIV research and its applications.
Its 2025 edition, which runs until Thursday, features hundreds of sessions and presentations focused on translating scientific breakthroughs into real-world impact, with a particular emphasis on solutions for regions and populations most affected by HIV.
UNI XINHUA GNK
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
14 million children did not receive a single vaccine in 2024, says UN
More than 14 million children did not receive a single vaccine last year about the same number as the year before according to UN health officials. Nine countries accounted for more than half of those unprotected children. In their annual estimate of global vaccine coverage, released Tuesday, the World Health Organization and UNICEF said about 89 per cent of children under one year old got a first dose of the diphtheria, tetanus and whooping cough vaccine in 2024, the same as in 2023. About 85 per cent completed the three-dose series, up from 84 per cent in 2023. Officials acknowledged, however, that the collapse of international aid this year will make it more difficult to reduce the number of unprotected children. In January, US President Trump withdrew the country from the WHO, froze nearly all humanitarian aid and later moved to close the US AID Agency. And last month, Health Secretary Robert F. Kennedy Jr. said it was pulling the billions of dollars the US had previously pledged to the vaccines alliance Gavi, saying the group had "ignored the science". Kennedy, a longtime vaccine skeptic, has previously raised questions the diphtheria, tetanus and whooping cough vaccine which has proven to be safe and effective after years of study and real-world use. Vaccines prevent 3.5 million to 5 million deaths a year, according to UN estimates. "Drastic cuts in aid, coupled with misinformation about the safety of vaccines, threaten to unwind decades of progress," said WHO Director-General Tedros Adhanom Ghebreyesus. UN experts said that access to vaccines remained "deeply unequal" and that conflict and humanitarian crises quickly unraveled progress; Sudan had the lowest reported coverage against diphtheria, tetanus and whooping cough. The data showed that nine countries accounted for 52 per cent of all children who missed out on immunisations entirely: Nigeria, India, Sudan, Congo, Ethiopia, Indonesia, Yemen, Afghanistan and Angola. WHO and UNICEF said that coverage against measles rose slightly, with 76 per cent of children worldwide receiving both vaccine doses. But experts say measles vaccine rates need to reach 95 per cent to prevent outbreaks of the extremely contagious disease. WHO noted that 60 countries reported big measles outbreaks last year. The US is now having its worst measles outbreak in more than three decades, while the disease has also surged across Europe, with 1,25,000 cases in 2024 twice as many as the previous year, according to WHO. Last week, British authorities reported a child died of measles in a Liverpool hospital. Health officials said that despite years of efforts to raise awareness, only about 84 per cent of children in the UK are protected. "It is hugely concerning, but not at all surprising, that we are continuing to see outbreaks of measles," said Helen Bradford, a professor of children's health at University College London. "The only way to stop measles spreading is with vaccination," she said in a statement. "It is never too late to be vaccinated even as an adult. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Indian Express
4 hours ago
- Indian Express
Clinics on Cloud: Pune-based startup brings Health ATMs to rural areas
Clinics on Cloud, a health tech company founded by Pune-based couple Abhay and Manashrri Agarwal, has announced the large-scale deployment of its AI-powered Health ATMs across underserved regions. A health ATM combines a physical kiosk with telemedicine and point-of-care devices designed to provide accessible and affordable healthcare. Abhay Agarwal, founder and CEO of Clinics on Cloud, spoke about the urgent need to modernise rural healthcare. 'India's rural population often lacks access to timely diagnostic services, which delays treatment and increases health risks. Our Health ATM concept is designed to bridge this critical gap—bringing over 65 rapid diagnostic tests to the doorsteps of rural citizens,' he said. This comprehensive preventive health screening can be done in 10 minutes and can also help reduce medical costs, Agarwal added. These AI-enabled Health ATMs can perform a wide array of health checks—from routine vitals and blood pressure to advanced screenings for diabetes, cardiac conditions, hemoglobin levels, and infectious diseases like dengue, malaria, Covid-19, and HIV. The tests include a general health check-up (body mass index, pulse, SPO2, body temperature, muscle mass, bone mass and so on), urine rapid test, ear and eye tests, pulmonary function tests among others. Reports are generated instantly, ensuring timely medical consultation through telemedicine, even in remote regions. Manashrri Agarwal, co-founder and Managing Director of Clinics on Cloud, added that the goal is to make preventive healthcare accessible, affordable, and accurate for every Indian—regardless of location. 'These Health ATMs have an accuracy rate of over 95% and operate at a fraction of the cost of traditional labs,' she said. In a unique collaboration with distribution partner DynaBlaze, Clinics on Cloud has engineered the Health ATMs to function without the need for electricity or internet, making them perfectly suited for deployment in electricity-deficient rural zones. The machines are available through EMI and rental options, also creating local employment opportunities by training health operators in villages. Ajay Dhumane, spokesperson for DynaBlaze, said, 'This is more than a healthcare solution—it's a rural empowerment movement. By enabling easy ownership and operation of Health ATMs, we're nurturing rural entrepreneurship while transforming public health outcomes.' According to Agarwal, till date, over 80 lakh individuals have benefited from this initiative, with 3000 Health ATMs installed in 150+ Indian cities and seven international markets.
Time of India
5 hours ago
- Time of India
TB screening finds 37 cases in urban slums
N ew Delhi: Delhi health department's ongoing community-based tuberculosis (TB) screening drive in urban slums has identified 37 cases from among 9,200 people screened so far. The initiative, which uses artificial intelligence (AI)-powered diagnostics, aims to facilitate early detection, interrupt transmission chains, and swiftly reduce TB prevalence in high-risk areas. The first phase of the programme targets six high-burden National TB Elimination Program (NTEP) districts — Nehru Nagar, Narela, Karawal Nagar, Moti Nagar, BJRM and Shastri Park. You Can Also Check: Delhi AQI | Weather in Delhi | Bank Holidays in Delhi | Public Holidays in Delhi The department has deployed 21 portable AI-powered X-ray units, supported by 21 radiographers, 21 field officers and 7 laboratory technicians. According to the India TB Prevalence Survey (2019–2021), Delhi has the highest TB burden in the country, with a prevalence of 747 cases per lakh of the population and an infection rate of 61% (range: 57–65%). The capital has launched an intensive, slum-focused TB screening campaign designed to identify undiagnosed cases and rapidly reduce community transmission. Officials said the campaign aims to screen 40 lakh people over three years, with a goal of reducing TB prevalence by 25% in the targeted districts. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like An engineer reveals: One simple trick to get internet without a subscription Techno Mag Learn More Undo Camps have been set up in both public and private spaces to demonstrate handheld X-ray technologies. A hub-and-spoke model has been implemented to ensure timely sputum collection and transportation, with a focus on TB-HIV co-infection for integrated care. Support from the Indian Council of Medical Research (ICMR) strengthened the effort, with the provision of 10 PathoDetect molecular testing machines, 7 additional handheld X-ray units, and ongoing technical guidance, said officials. A comprehensive advocacy, social mobilisation, and communication strategy is being rolled out to raise awareness, reduce stigma, and encourage active participation in slum clusters. The department has mapped over 600 slum localities across Delhi for coverage. The screening is prioritising high-risk groups such as people with diabetes, hypertension, compromised immunity, TB patient contacts, migrant labourers, the homeless, residents of JJ clusters and unauthorised colonies, and others living in densely populated areas.
